Charles River Laboratories
466 hedge funds and large institutions have $8.14B invested in Charles River Laboratories in 2020 Q2 according to their latest regulatory filings, with 89 funds opening new positions, 153 increasing their positions, 165 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
466
Holders Change
+50
Holders Change %
+12.02%
% of All Funds
9.58%
Holding in Top 10
13
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+8.33%
% of All Funds
0.27%
New
89
Increased
153
Reduced
165
Closed
37
Calls
$73M
Puts
$57.7M
Net Calls
+$15.3M
Net Calls Change
-$3.11M
Top Buyers
1 |
BlackRock
New York
|
+$153M |
2 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
+$52.2M |
3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$47M |
4 |
THP
Tower House Partners
London,
United Kingdom
|
+$40.1M |
5 |
LCM
Lakewood Capital Management
New York
|
+$39.2M |
Top Sellers
1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$108M |
2 |
HM
HealthCor Management
New York
|
-$84.4M |
3 |
Renaissance Technologies
New York
|
-$52.8M |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$41M |
5 |
CCM
Channing Capital Management
Chicago,
Illinois
|
-$40.1M |